Small Cap Stock Indaptus Therapeutics Inc (INDP) Is A Buy – Analysts

Indaptus Therapeutics Inc (NASDAQ:INDP) has a beta value of 1.56 and has seen 364.44 million shares traded in the last trading session. The company, currently valued at $8.02M, closed the last trade at $0.5 per share which meant it gained $0.23 on the day or 85.12%% during that session. The INDP stock price is -384.0% off its 52-week high price of $2.42 and 46.0% above the 52-week low of $0.27. If we look at the company’s 10-day average daily trading volume, we find that it stood at 37.05 million shares traded. The 3-month trading volume is 412.48K shares.

Indaptus Therapeutics Inc (NASDAQ:INDP) trade information

Sporting 85.12%% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the INDP stock price touched $0.5 or saw a rise of 29.7%. Year-to-date, Indaptus Therapeutics Inc shares have moved -79.92%, while the 5-day performance has seen it change 53.94%. Over the past 30 days, the shares of Indaptus Therapeutics Inc (NASDAQ:INDP) have changed 31.58%. Short interest in the company has seen 1.02 million shares shorted with days to cover at 1.56.

Indaptus Therapeutics Inc (INDP) estimates and forecasts

The company’s shares have lost -44.99% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 57.27% over the past 5 years. Earnings growth for 2025 is a modest 16.15% while over the next 5 years, the company’s earnings are expected to increase by 18.55%.

INDP Dividends

Indaptus Therapeutics Inc is expected to release its next earnings report on 2025-May-14 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Indaptus Therapeutics Inc (NASDAQ:INDP)’s Major holders

Insiders own 36.87% of the company shares, while shares held by institutions stand at 13.08% with a share float percentage of 20.73%. Investors are also buoyed by the number of investors in a company, with Indaptus Therapeutics Inc having a total of 21.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 0.26 million shares worth more than $0.54 million. As of 2024-06-30, VANGUARD GROUP INC held 3.0355% of shares outstanding.

The other major institutional holder is INVESTMENT HOUSE LLC, with the holding of over 0.1 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.22 million and represent 1.2134% of shares outstanding.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.